Skip to main content
Sanofi Pasteur's smallpox vaccine acquired by Emergent for $125M
7/17/2017

Sanofi Pasteur's smallpox vaccine ACAM2000 business has been purchased by Emergent BioSolutions for up to $125 million. Under the terms of the deal, Sanofi will get $97.5 million upfront and up to $27.5 million for regulatory and manufacturing-related milestones.

Full Story: